GGrantIndex
Sort

59,101 grants matching hypertension

Statistical and Data Coordinating Center for the ATACH - 2

$892,008
Yuko Y Palesch · Medical University Of South Carolina · U01 · FY2014 · NS

Genomic Medicine Pilot For Hypertension And Kidney Disease In Primary Care

$891,423
Carol R Horowitz · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · HG

Mechanisms of sphingolipid signaling in vascular health and disease

$891,262
Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2022 · HL

THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL

$891,247
Barry Davis · University Of Texas Hlth Sci Ctr Houston · N01 · FY2014 · HL

The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)

$890,479
Gregory D Kirk · Johns Hopkins University · R01 · FY2008 · HL

Health Disparities and Stress Hypothesis

$890,040
R Jay R Jay Turner · Vanderbilt University · R01 · FY2010 · AG

Data Coordinating Center for Hemodialysis Pilot Studies Consortium

$890,000
Laura M Dember · University Of Pennsylvania · U01 · FY2016 · DK

Data Coordinating Center for Hemodialysis Pilot Studies Consortium

$889,999
Laura M Dember · University Of Pennsylvania · U01 · FY2015 · DK

Data Coordinating Center for Hemodialysis Pilot Studies Consortium

$889,998
Laura M Dember · University Of Pennsylvania · U01 · FY2017 · DK

The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)

$889,680
Gregory D Kirk · Johns Hopkins University · R01 · FY2009 · HL

Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism

$889,418
Arvin Garg · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · NR

Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice

$889,277
Susana T Valente · University Of Florida · R01 · FY2024 · AI

Pre-clinical and Clinical Studies of Cobinamide, a New Cyanide Detoxifying Agent

$889,246
Gerry R Boss · University Of California, San Diego · U01 · FY2006 · NS

The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation

$889,086
Tracey Simon · Brigham And Women'S Hospital · R01 · FY2023 · HL

Characterization And Functional Significance Of P450 Arachidonate Epoxygenases

$889,054
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus

$888,853
Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2009 · HL

Women's Health Study: Continued Follow-Up

$888,766
Brigham And Women'S Hospital · R01 · FY2005 · HL

Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging

$888,748
Olga V Fedorova · National Institute On Aging · ZIA · FY2017 · AG

Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function

$888,382
Amil M Shah · Brigham And Women'S Hospital · R01 · FY2017 · HL

Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study

$888,330
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

Proteomics of Hypertension and Alzheimer's Disease in African Americans

$888,255
Rena A. S. Robinson · Vanderbilt University · R01 · FY2019 · AG

Mechanisms of sphingolipid signaling in vascular health and disease

$887,736
Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2023 · HL

Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago)

$887,582
Abel N. Kho · Northwestern University At Chicago · UG3 · FY2020 · HL

A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure

$887,140
Lawrence Mahan · Madeleine Pharmaceuticals, Inc. · R44 · FY2020 · HL

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

$886,843
Anand Vaidya · Brigham And Women'S Hospital · R01 · FY2020 · HL